ArticleOncotarget2018

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth.

Janet K Parrish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.